QuickView for Mitogen-activated protein kinase 14 (biogroup)

1. NSCLC PC9 cells selected for gefitinib sensitivity or resistance treated with EGF and gefitinib
2. Analysis of bone metastases of human non-small cell lung cancer (NSCLC) in mice
3. HeLa cells transfected with WT or single base mismatch 193-MAPK13 siRNA
4. L1000 CMAP - Hepatocellular carcinoma Hep G2 cells with shRNA-mediated gene knockdown (1 of 2)
5. Drug target sets for approved compounds

There were no matches for Mitogen-activated protein kinase 14

1. Randomized Phase II Study of AZD6244 (Mitogen-activated Protein Kinase Inhibitor) MEK-Inhibitor With…
2. Phase Ib Study of PI3(Phosphoinositol 3)-Kinase Inhibitor Copanlisib With MEK (Mitogen-activated Pro…
3. Mitogen Activated Protein Kinase Kinase (MEK1/2) Inhibitor Selumetinib (AZD6244 Hydrogen Sulfate) in…
4. P38 Mitogen-activated Protein (Map) Kinase Inhibitor (SB-681323)Study In Patients With Neuropathic P…
5. A Study of JZP815 Oral Capsules in Adult Participants With Advanced or Metastatic Solid Tumors Harbo…